Pacira BioSciences, Inc.

Pacira BioSciences, Inc. is a Delaware corporation that serves as the holding company for its California operating subsidiary, Pacira Pharmaceuticals, Inc. The company's mission is to deliver innovative, non-opioid pain therapies. Pacira BioSciences, Inc. was incorporated in Delaware in December 2006 as Blue Acquisition Corp., changing its name to Pacira, Inc. in June 2007, then to Pacira Pharmaceuticals, Inc. in October 2010, and finally to Pacira BioSciences, Inc. in April 2019. Its principal executive offices and corporate headquarters are located in Brisbane, California. The company has expanded through several acquisitions. In March 2007, it acquired Pacira Pharmaceuticals, Inc. from SkyePharma Holdings, Inc. (now Vectura Group Limited, a subsidiary of Molex Asia Holdings, Ltd.). In April 2019, Pacira BioSciences, Inc. acquired MyoScience, Inc., a privately held medical technology company. This was followed by the acquisition of Flexion Therapeutics, Inc., a publicly traded biopharmaceutical company, in November 2021. Most recently, in February 2025, the company acquired GQ Bio Therapeutics GmbH, a privately-held biopharmaceutical company. Key trademarks and service marks owned by Pacira include Pacira®, EXPAREL®, ZILRETTA®, iovera®°, and the Pacira logo.